iSpecimenISPC
About: iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
Employees: 53
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
43% more capital invested
Capital invested by funds: $69.1K [Q1] → $98.6K (+$29.5K) [Q2]
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
9% more funds holding
Funds holding: 11 [Q1] → 12 (+1) [Q2]
0.85% less ownership
Funds ownership: 3.29% [Q1] → 2.44% (-0.85%) [Q2]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Research analyst outlook
We haven’t received any recent analyst ratings for ISPC.